548 related articles for article (PubMed ID: 31401321)
21. Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Zhang X; Li P; Hua Y; Ji P; Yao W; Ma Q; Yuan Z; Wen Y; Yang C; Wei Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():51-60. PubMed ID: 29331744
[TBL] [Abstract][Full Text] [Related]
22. [Liquid chromatography-mass spectrometry-based metabolomics study of the efficacy of Chinese medicine asthma-relieving decoction on respiratory syncytial virus infection].
Ouyang Y; Chi L; Xu C; Zhao X; Cui Z
Se Pu; 2021 Mar; 39(3):281-290. PubMed ID: 34227309
[TBL] [Abstract][Full Text] [Related]
23. Xuefu zhuyu decoction improves cognitive impairment in experimental traumatic brain injury via synaptic regulation.
Zhou J; Liu T; Cui H; Fan R; Zhang C; Peng W; Yang A; Zhu L; Wang Y; Tang T
Oncotarget; 2017 Sep; 8(42):72069-72081. PubMed ID: 29069769
[TBL] [Abstract][Full Text] [Related]
24. Urinary metabolomics research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats based on
Liu Y; Jin Z; Qin X; Zheng Q
J Pharm Pharmacol; 2020 May; 72(5):748-760. PubMed ID: 32128823
[TBL] [Abstract][Full Text] [Related]
25. Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS.
Liu M; Liu X; Wang H; Xiao H; Jing F; Tang L; Li D; Zhang Y; Wu H; Yang H
J Ethnopharmacol; 2016 Mar; 180():1-11. PubMed ID: 26806568
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
27. Effects and mechanisms of Shaofu-Zhuyu decoction and its major bioactive component for Cold - Stagnation and Blood - Stasis primary dysmenorrhea rats.
Huang X; Su S; Duan JA; Sha X; Zhu KY; Guo J; Yu L; Liu P; Shang E; Qian D
J Ethnopharmacol; 2016 Jun; 186():234-243. PubMed ID: 27060631
[TBL] [Abstract][Full Text] [Related]
28. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
[TBL] [Abstract][Full Text] [Related]
29. VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury.
Xia Z; Liu W; Zheng F; Huang W; Xing Z; Peng W; Tang T; Luo J; Yi L; Wang Y
ASN Neuro; 2020; 12():1759091420910957. PubMed ID: 32146828
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometry-based urinary metabolomics for the investigation on the mechanism of action of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves against ischemic stroke in rats.
Wang R; Shi L; Liu S; Liu Z; Song F; Sun Z; Liu Z
J Ethnopharmacol; 2019 Sep; 241():111969. PubMed ID: 31125596
[TBL] [Abstract][Full Text] [Related]
31. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
[TBL] [Abstract][Full Text] [Related]
33. Intergrated metabonomic study of the effects of Guizhi Fuling capsule intervention on primary dysmenorrheal using RP-UPLC-MS complementary with HILIC-UPLC-MS technique.
Lang L; Meng Z; Sun L; Xiao W; Zhao L; Xiong Z
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28906007
[TBL] [Abstract][Full Text] [Related]
34. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
[TBL] [Abstract][Full Text] [Related]
35. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
36. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
37. Validation of biomarkers in cardiotoxicity induced by Periplocin on neonatal rat cardiomyocytes using UPLC-Q-TOF/MS combined with a support vector machine.
Li A; Guo X; Xie J; Liu X; Zhang Z; Li Y; Zhang Y
J Pharm Biomed Anal; 2016 May; 123():179-85. PubMed ID: 26924293
[TBL] [Abstract][Full Text] [Related]
38. Urine and plasma metabonomics coupled with UHPLC-QTOF/MS and multivariate data analysis on potential biomarkers in anemia and hematinic effects of herb pair Gui-Hong.
Li S; Lin H; Qu C; Tang Y; Shen J; Li W; Yue S; Kai J; Shang G; Zhu Z; Zhang C; Liu P; Yan H; Zhang L; Qian L; Qian D; Duan JA
J Ethnopharmacol; 2015 Jul; 170():175-83. PubMed ID: 25985767
[TBL] [Abstract][Full Text] [Related]
39. Urine and plasma metabolomics study on potential hepatoxic biomarkers identification in rats induced by Gynura segetum.
Qiu S; Zhang H; Fei Q; Zhu F; Wang J; Jia X; Chen B
J Ethnopharmacol; 2018 Apr; 216():37-46. PubMed ID: 29353003
[TBL] [Abstract][Full Text] [Related]
40. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
